Avalo Therapeutics Inc (AVTX)
9.64
-0.75
(-7.22%)
USD |
NASDAQ |
May 16, 16:00
9.92
+0.28
(+2.90%)
After-Hours: 20:00
Avalo Therapeutics Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.133M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.039M |
| June 30, 2022 | -0.056M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.011M |
| September 30, 2021 | -0.081M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.021M |
| December 31, 2020 | -0.391M |
| September 30, 2020 | -0.063M |
| June 30, 2020 | 12.84M |
| March 31, 2020 | -1.251M |
| December 31, 2019 | -0.181M |
| September 30, 2019 | -0.0051M |
| June 30, 2019 | -0.091M |
| Date | Value |
|---|---|
| March 31, 2019 | -0.166M |
| December 31, 2018 | -0.4994M |
| September 30, 2018 | 1.391M |
| June 30, 2018 | -0.0067M |
| March 31, 2018 | -0.0192M |
| December 31, 2017 | -18.90M |
| September 30, 2017 | -0.0062M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.0018M |
| December 31, 2016 | -0.0092M |
| September 30, 2016 | -0.0065M |
| June 30, 2016 | -0.0103M |
| March 31, 2016 | -0.0089M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.02M |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0195M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.251M
Minimum
Mar 2020
12.84M
Maximum
Jun 2020
0.5534M
Average
-0.021M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Imunon Inc | -3.304M |
| iBio Inc | 0.00 |
| Kodiak Sciences Inc | -27.80M |
| Petros Pharmaceuticals Inc | -- |
| Ocugen Inc | -2.352M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.766M |
| Cash from Financing (Quarterly) | 0.001M |
| Free Cash Flow | -30.68M |
| Free Cash Flow Per Share (Quarterly) | -3.45 |
| Free Cash Flow to Equity (Quarterly) | -2.766M |
| Free Cash Flow to Firm (Quarterly) | -2.766M |
| Free Cash Flow Yield | -1.15K% |